Collaboration among physicians, Novartis, and the qualified Treatment Centre is crucial to delivering this personalised treatment
Patient
Identification
1. Flexible Collection
and Cryopreservation
2. Manufacturing
4. Flexibility of Inpatient or
Outpatient Infusion
3. Specialised Shipping
For full safety information, please see the Summary of Product Characteristics.
You are now leaving KYMRIAH.com and moving to a site that is for qualified treatment centres only. A log-in and password will be required to access information on this site.
Coming soon
A list of qualified treatment centres near you
You are now leaving KYMRIAH.com and moving to a site that is for qualified treatment centres only. A log-in and password will be required to access information on this site.
You are now leaving KYMRIAH.com and will be redirected to Novartis.com to review the press release.